Keebeck Wealth Management Purchases Shares of 351,976 BlackRock Capital Allocation Term Trust $BCAT

Keebeck Wealth Management acquired a new position in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) in the 2nd quarter, HoldingsChannel reports. The firm acquired 351,976 shares of the company’s stock, valued at approximately $5,607,000. BlackRock Capital Allocation Term Trust accounts for about 0.5% of Keebeck Wealth Management’s holdings, making the stock its 29th biggest position.

A number of other large investors also recently modified their holdings of BCAT. Geneos Wealth Management Inc. boosted its position in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after buying an additional 1,582 shares during the last quarter. N.E.W. Advisory Services LLC grew its holdings in BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock worth $34,000 after buying an additional 1,200 shares in the last quarter. McIlrath & Eck LLC grew its holdings in BlackRock Capital Allocation Term Trust by 169.6% during the first quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock worth $44,000 after buying an additional 1,969 shares in the last quarter. Parallel Advisors LLC purchased a new stake in BlackRock Capital Allocation Term Trust in the 3rd quarter valued at $47,000. Finally, Brown Brothers Harriman & Co. raised its position in BlackRock Capital Allocation Term Trust by 450.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after buying an additional 4,500 shares during the last quarter. Institutional investors own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Price Performance

BCAT opened at $15.89 on Friday. BlackRock Capital Allocation Term Trust has a fifty-two week low of $13.73 and a fifty-two week high of $16.20. The company’s 50-day moving average is $15.79 and its 200 day moving average is $15.31.

BlackRock Capital Allocation Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be issued a dividend of $0.2542 per share. This represents a c) dividend on an annualized basis and a yield of 19.2%. The ex-dividend date is Tuesday, September 15th.

About BlackRock Capital Allocation Term Trust

(Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

See Also

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.